This webinar will provide an overview of the current state of circulating tumor cell (CTC) enumeration for clinical use in metastatic breast cancer.
Dr. Massimo Cristofanilli, Associate Director of Translational Research and Precision Medicine at Robert Lurie Cancer Center, Northwestern University, will review the evidence, as well as clinical case studies demonstrating how CTCs can be utilized in clinical practice and clinical research studies in metastatic breast cancer.
A prominent figure in the liquid biopsy field, Dr. Cristofanilli led a pivotal study demonstrating the prognostic value of CTC enumeration using the semiautomated CellSearch technology. CellSearch has been cleared by the US Food and Drug Administration for detecting and enumerating circulating tumor cells to help manage patients with metastatic breast, prostate, and colorectal cancers.
Dr. Cristofanilli will discuss future developments and applications of CTCs in oncology. The session will wrap up with a live Q&A with Dr. Cristofanilli.